Clinical pharmacology of antidiabetic drugs: what can be expected of their use
and safety concerns around promoting apoptosis given the potential for off-target effects in stem cell populations that share some SASP markers
Heres what I want you to know: we do not have strong clinical trial evidence proving that very small doses deliver the big claims being marketed
They also reduce liver damage and inhibit tumor progression [43, 95]
In addition, it functions as an autocrine and paracrine agent, regulating the innate immune system, cell maturation, and differentiation (131133)
Wegovy and Zepbound are now fully FDA approved for chronic weight management, regardless of diabetes status, as long as you meet the BMI or health condition criteria